4527

ROHTO PHARMACEUTICAL CO.,LTD.

ロート製薬株式会社
Pharmaceutical
Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin, lip balms, sunscreens, functional cosmetics, etc.; medicine for internal use, such as digestive and herbal medicines; regenerative medicines; OTC pharmaceutical products, including ophthalmic, dermatological, gastrointestinal, and diagnostic drugs, as well as Chinese herbal medicines, and supplements. In addition, the company operates beauty counters that provide beauty and health services; and manufactures and sells diagnostic reagents, as well as provides investment management services; and contract development and manufacturing services. The company was formerly known as Yamada Pharmaceutical and changed its name to Rohto Pharmaceutical Co.,Ltd. in September 1949. The company was founded in 1899 and is headquartered in Osaka, Japan.
← Companies
Price
¥2,381
Market Cap
¥538.0B
Ent. Value
¥485.7B
Net Cash
¥52.3B
Shares Out.
226.0M
P / E
17.5×
EV / EBIT
12.5×
P / Book
2.07×
P / NCAV
7.98×
Div. Yield
1.51%
Financials
Metric FY 2024
EDINET ↗ 		FY 2023
EDINET ↗ 		FY 2022
EDINET ↗ 		FY 2021
EDINET ↗
Net Sales ¥308.6B ¥270.8B ¥238.7B ¥199.6B
Cost of Sales ¥133.7B ¥113.6B ¥101.2B ¥83.2B
Gross Profit ¥174.9B ¥157.3B ¥137.4B ¥116.5B
SG&A ¥136.0B ¥117.2B ¥103.5B ¥87.1B
Operating Income ¥38.9B ¥40.0B ¥34.0B ¥29.3B
Non-Operating Income ¥3.5B ¥3.5B ¥3.7B ¥1.6B
Dividend Income ¥556M ¥486M ¥461M ¥383M
Interest Income ¥1.2B ¥1.5B ¥962M ¥368M
Non-Operating Expenses ¥2.0B ¥1.2B ¥2.1B ¥1.8B
Interest Expense ¥949M ¥196M ¥247M ¥248M
Ordinary Income ¥40.4B ¥42.4B ¥35.6B ¥29.1B
Pre-tax Income ¥42.3B ¥41.5B ¥34.3B ¥28.0B
Income Taxes ¥11.4B ¥10.1B ¥7.9B ¥6.8B
Current Tax ¥11.6B ¥10.0B ¥9.0B ¥7.5B
Deferred Tax ¥-247M ¥168M ¥-1.2B ¥-677M
Net Income (owners) ¥31.0B ¥30.9B ¥26.4B ¥21.0B
Minority Interest ¥-54M ¥457M ¥52M ¥131M
Comprehensive Income ¥35.0B ¥43.6B ¥36.5B ¥26.8B
EBITDA ¥52.1B ¥48.7B ¥41.8B ¥37.0B
Goodwill Amort. (J-GAAP) ¥1.5B ¥436M ¥383M ¥457M
EPS ¥136.11 ¥135.61 ¥115.62 ¥184.26
Shares Outstanding 226.0M 228.1M 228.1M 114.1M
Shares Issued (total) 236.2M 236.2M 236.2M 118.1M
Treasury Shares 10.2M 8.0M 8.0M 4.0M